Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
04 2019
Historique:
accepted: 15 11 2018
pubmed: 16 3 2019
medline: 8 11 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

ABO blood group incompatibility between mother and fetus can lead to hemolytic disease of the fetus and newborn (HDFN). We present the first case of severe O/A HDFN associated with extremely high-titer (1:32 000) immunoglobulin G anti-A antibodies in a Cameroon mother. Cord blood analysis revealed severe fetal hemolytic anemia and conjugated hyperbilirubinemia. After exclusion of an underlying disease and other risk factors, cholestasis resolved after treatment with ursodeoxycholic acid, a red blood cell transfusion, and intravenous immunoglobulins. This case is presented to create awareness for a more severe course of ABO HDFN in nonwhite and non-European mother-child pairs.

Identifiants

pubmed: 30872329
pii: peds.2018-2859
doi: 10.1542/peds.2018-2859
pii:
doi:

Substances chimiques

Antibodies, Anti-Idiotypic 0
Immunoglobulin G 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Rens Zonneveld (R)

Department of Pediatrics and rens.zonneveld@gmail.com.

Laura van der Meer-Kapelle (L)

Department of Pediatrics and.

Marc Sylva (M)

Department of Pediatrics, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, Netherlands.

Anneke Brand (A)

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden University, Leiden, Netherlands.

Marianne Zijlstra (M)

Clinical Laboratory, Reinier de Graaf Gasthuis, Delft, Netherlands.

Henk Schonewille (H)

Department of Experimental Immunohematology, Sanquin, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH